Clinical Trials

Recruitment strategy that pairs use of electronic medical records with postal mailings shows cost-effectiveness and increased participation of under-represented groups

Study finds that glial fibrillary acidic protein levels in the blood can predict intracranial abnormalities on CT scans in patients with traumatic brain injury

Matthew M. Laughon, MD, MPH is a professor at the University of North Carolina (UNC) at Chapel Hill in the
department of pediatrics.

Mid-sized labs are joining larger commercial labs in the research testing space

The benefits of ending a trial early must be weighed carefully against the risks

The Control-IQ system, manufactured by Tandem Diabetes Care, is an "all-in-one" diabetes management device that automatically monitors and regulates blood glucose

For patients undergoing PCI, the choice of antiplatelet therapy can be critical to post-treatment success, and to minimize the chance of heart attack or stroke.

Trials need more people of color to generalize results to larger US population

The first effective MS treatments became available two decades ago, but the new study is the latest to demonstrate the much greater effectiveness of a new type of treatment

New platform is a web-native extension of Cytel’s world-renowned East® software for adaptive clinical trial design and analysis